ARCHIVES

NCI Initiatives: Two RFAs Planned In New Technologies for Molecular Biology

This article is from The Cancer Letter archive.

Vol. 22 No. 47 | December 6, 1996

Download PDF Visit The Full Archive

Related Articles

Herceptin Recommended As Adjuvant For HER2 Positive Early Breast Cancer

May 27, 2005

ODAC’s Dilemma: Proposed Indication Created By Reliance On PSA Screening and Hormonal Treatment

September 23, 2011

Ruffin Sworn In As Director, NIH Minority Health Center.

January 12, 2001

Four CIDAC Contracts Will Go To Cancer Research Centers; RFPs To Be Released January or February

December 20, 1974

Cooperative Groups: Decision To Form One Group Seemed “So Obvious”

August 7, 1998

NCI To Fund 29% Of Grants In 1990, With Budget Cuts

February 17, 1989